Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Imidazole based kinase inhibitors

Imidazole based kinase inhibitors

US Patent 7470713 · Granted Dec 30, 2008

Estimated economic value: $41,288,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heterocyclic mitochondrial activity inhibitors and uses thereof2025
Heterocyclic mitochondrial activity inhibitors and uses thereof2023
Compounds and use thereof in the expansion of stem cells and/or progenitor cells2023
Heterocyclic compounds as inhibitors of platelet aggregation2019
Imidazothiadiazole derivatives as protease activated receptor 4 (PAR4) inhibitor2018
Hepatitis C virus inhibitors2017
Imidazotriazine and imidazodiazine compounds2017
Imidazothiadiazole and imidazopyridazine derivatives as protease activated recep2016
Imidazothiadiazole and imidazopyridazine derivatives as protease activated recep2016
Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor m2016
Assay for inhibitors of CIP/KIP protein degradation2016
Hepatitis C virus inhibitors2016